Q-interactive Scheduled Downtime: The Q-interactive website will undergo maintenance on 24 January (3:00 am–3:40 am GMT for version 9.1) and 26 January (4:00 pm–6:30 pm GMT). The website will be temporarily unavailable, but the Assess app will remain accessible.

Please Note: Our 2025 price increase will take effect on January 17th.

BDI - FastScreen for Medical Patients

BDI
Quickly screen for depression in adolescents and adults with the new BDI® – FastScreen for Medical Patients. A new version of the Beck Depression Inventory®–II designed specifically for medical patients. BDI® – FastScreen is a reliable 7-item self-report instrument useful for case-finding

Choose from our formats

  • Kits

    Starter & complete kits, print & digital

    1 option

    From £148.10
  • Test forms & reports

    Booklets, record forms, answer sheets, report usages & subscriptions

    1 option

    From £75.60
  • Support materials

    Manuals, stimulus books, replacement items & other materials

    1 option

    From £112.40
  • All products

    All tests and materials offered for BDI

    3 options

    From £75.60
- of 3 results
  • BDI-FastScreen Complete Kit
    9780158019413 Qualification Level B

    Includes Manual and Pad of 50 Record Forms

    £148.10 Excl. VAT

  • BDI-FastScreen Manual
    9780158019420 Qualification Level B

    £112.40 Excl. VAT

    Estimated to ship:More than 12 weeks
  • BDI-FastScreen Record Forms
    9780158019437 Qualification Level B

    Pad of 50

    £75.60 Excl. VAT

Overview

Publication date:

2000

Age range:

13 through 80 years

Completion time:

Less than 5 minutes

Product Details

Features and Benefits

  • This cost-effective, focused evaluation tool is self-administered in just a few minutes and easily scored by office staff
  • Measures the severity of depressive symptoms corresponding to the psychological, nonsomatic criteria for diagnosing major Depressive Disorders in the DSM– IV.
  • Helps quantify depression, while excluding symptoms that might be related to medical problems. (Evaluates depression in patients whose behavioral and somatic symptoms attributable to biological, medical, alcohol and/or substance abuse problems may confound diagnosis.)